| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | — | — | — | — | — | — |
| 3d | — | — | — | — | — | — |
| 1w | — | — | — | — | — | — |
| 1m | — | — | — | — | — | — |
| 3m | — | — | — | — | — | — |
| 6m | — | — | — | — | — | — |
| 1y | — | — | — | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
Charter Communications is attractively repriced due to interest rate concerns despite fundamentally sound debt structure. Strong free cash flow yield of 30%+ and elevated option premiums support a bull thesis to $200.
Author believes long-term treasury yields are near a bottom and expects recovery/upside in TLT prices as yields revert. Considering leveraged long exposure via futures on the 30-year curve.
ServiceTitan trades at $57, between a 12% growth/4% terminal case ($34) and a mid-teens growth/25% FCF margin base case ($78), suggesting upside from current levels with reasonable growth and margin assumptions.
Cigna trades at ~9.2x forward P/E on 2026 guidance, appearing undervalued relative to fundamentals. A conservative DCF valuation suggests ~$390/share fair value against current ~$279/share, with substantial margin of safety despite regulatory risks already priced in.
Cigna trades at ~9.2x forward P/E with 2026 EPS guidance of $30.45, well below the author's conservative DCF valuation of ~$390/share. Despite acknowledged PBM regulation risks, the discount appears excessive given strong revenue growth (+7% YoY), operating income growth (+6% YoY), and substantial cash generation ($9.6B OCF, $6.5B buyback authorization).
End of results.